<DOC>
	<DOCNO>NCT02459431</DOCNO>
	<brief_summary>Randomized control trial determine efficacy different needle size ( 22G 21G ) use endobronchial ultrasound guide transbronchial needle aspiration</brief_summary>
	<brief_title>RCT Comparing 21 22 G Needle Diagnosis Sarcoidosis EBUS TBNA</brief_title>
	<detailed_description>Among bronchoscopic technique diagnosis sarcoidosis , transbronchial needle aspiration ( TBNA ) lymph node emerge particularly useful supplement previously know endobronchial transbronchial biopsy . The efficacy safety conventional TBNA well establish . With improvement technology , last decade see use convex probe endobronchial ultrasonography ( EBUS ) guide TBNA direct vision . This technique minimally invasive alternative mediastinoscopy , offer additional advantage choose appropriate node sample basis echogenicity . Studies subsequently demonstrate superiority EBUS TBNA conventional TBNA . Once role TBNA diagnostic bronchoscopy establish , technical aspect procedure become topic research . Needle size use TBNA one important factor . Apparently , large needle , good tissue yield hence improve diagnostic capability . Conventional TBNA usually perform 19G needle , though vary size use different study ( 18 , 21 , 22 , 26G ) . On hand , EBUS-TBNA perform 22G needle . More recently 21G needle use purpose . There conflict report literature , two needle size compare regard adequacy sample , accuracy diagnosis rate complication . Moreover , study undertake far do center malignancy predominant diagnosis . Whether needle size use EBUS TBNA impact diagnose benign disease like sarcoidosis still clear , hence study plan . The investigator hypothesize perform EBUS-TBNA use 21G needle may enable identification intact compact granuloma sarcoidosis , hence well diagnostic yield use 22G needle .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>Age â‰¥18 year Clinicoradiological suspicion sarcoidosis endobronchial ultrasound guide transbronchial needle aspiration contemplate Enlarged hilar mediastinal lymph node &gt; 10 mm ( axis ) compute tomography chest Hypoxemia ( SpO2 &lt; 92 % ) inspire fraction oxygen 0.3 Treatment systemic glucocorticoid 2 week precede three month Diagnosis sarcoidosis possible another minimally invasive technique skin biopsy peripheral lymph node biopsy Failure provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>